Publications

These publications are examples of research made possible with data from CanPath and its regional cohorts.

2024

Ultra-processed foods consumption, depression, and the risk of diabetes complications in the CARTaGENE project: a prospective cohort study in Quebec, Canada

Authors: Akankasha Sen, Anne-Sophie Brazeau, Sonya Deschênes, Hugo Ramiro Melgar-Quiñonez, Norbert Schmitz 

Researchers examined the association between depression, ultra-processed food consumption (UPFs), and the risk of developing diabetes-specific complications in adults with type 2 diabetes. Data from participants enrolled in CARTaGENE were used. Over 7 years, 105 individuals developed diabetes-related complications. Participants with high depressive symptoms and high levels of UPF consumption had a higher risk of diabetes complications compared to those without depressive symptoms and low levels of UPFs in their diet. When high depressive symptoms and antidepressant use were combined with high UPF consumption, the risk of diabetes complications was higher.

Read Publication
2023

The role of ultra-processed food consumption and depression on type 2 diabetes incidence: a prospective community study in Quebec, Canada

Authors: Akankasha Sen, Anne-Sophie Brazeau, Sonya Deschênes, Hugo Ramiro Melgar-Quiñonez, Norbert Schmitz

Researchers explored the link between depression and consumption of highly processed foods as potential risk factors for developing type 2 diabetes. Using CARTaGENE data, findings suggest that individuals with high depressive symptoms and high consumption of ultra-processed foods had the highest risk of developing type 2 diabetes.

Read Publication
2022

The role of ultra-processed food consumption and depression on type 2 diabetes incidence: a prospective community study in Quebec, Canada

Authors: Akankasha Sen, Anne-Sophie Brazeau, Sonya Deschênes, Hugo Ramiro Melgar-Quiñonez, Norbert Schmitz

Researchers analyzed the association between depression and ultra-processed food (UPF) consumption as risk factors for developing type 2 diabetes (T2D) using baseline data (2009-2010) from 3,880 CARTaGENE participants. Participants with high depressive symptoms and high UPF consumption were at the highest risk for T2D. The study suggests that early management and monitoring of both risk factors could be essential for diabetes prevention.

Read Publication